Skye Bioscience (SKYE) has released an update to notify the public and investors about a regulation fd disclosure.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
On January 29, 2024, the Company issued a press release regarding a Private Placement and provided it as part of a Current Report. The information contained within, including an attached presentation, is for informational purposes and is not considered legally filed under the Securities Exchange Act nor is it to be included in the Company’s filings under the Securities Act.
For further insights into SKYE stock, check out TipRanks’ Stock Analysis page.